Supreme Court decision on abortion drug mifepristone

Demonstrators support abortion rights at the US Supreme Court in Washington, DC, April 15, 2023.

Andrew Caballero-Reynolds | AFP | Getty Images

Supreme Court Justice Samuel Alito issued an order Wednesday making the abortion drug mifepristone available by mail without severe restrictions on its use until at least late Friday night.

Alito temporarily blocked restrictions last week Mifepristone It was imposed by a lower federal court until 11:59 p.m. Wednesday in response to an emergency motion by the Department of Justice and Danco Laboratories, distributors of the brand-name drug Mifeprex.

These restrictions will remain in place until 11:59 PM on Friday as a result of his new order.

Alito did not explain the reason for the delay.

But as a complicated legal battle unfolds over mifepristone, he and the rest of the Supreme Court are weighing whether to keep the lower court’s judgment pending or allow mifepristone restrictions to take effect. You will be given an additional two days to do so.

Two separate federal courts have handed down conflicting rulings against the Food and Drug Administration regarding drug availability.

Earlier this month, U.S. Judge Matthew Kaksmalik for the Northern District of Texas pause FDA approval of mifepristone and all subsequent decisions made by the FDA to regulate the drug.

US Court of Appeals for the Fifth Circuit partially blocked Kacsmaryk’s sweeping order went into effect a few days later, keeping FDA approval in effect but imposing severe restrictions on how mifepristone could be used and distributed. That ruling keeps mifepristone on the market, but the restrictions are so widespread that even in some states where abortion is legal, many women don’t have access to the drug.

Shortly after Kacsmaryk’s ruling, Judge Thomas Rice of the Eastern District of Washington said: FDA restricts access to mifepristone in 17 states and Washington DC

Mifepristone, used in combination with another drug called misoprostol, is the most common method of aborting pregnancies in the United States, accounting for about half of all abortions. According to the Centers for Disease Control Prevention and the Guttmacher Institute.

Kacsmaryk’s unprecedented ruling marks the first time a federal court has overturned the FDA’s determination that a drug is safe and effective, according to court filings from the Department of Justice, former FDA employees, and the pharmaceutical industry. was.

Former President Donald Trump appointed Kaksmalik. Senate Democrats voted unanimously against his nomination, citing concerns about his position on abortion and LGBTQ rights.

Appeals court restrictions include blocking the mailing of drugs, reimposing a doctor’s visit as a requirement to obtain drugs, and shortening the period during which women can use the pill to seven weeks pregnant. The court also blocked a generic version of mifepristone manufactured by GenBioPro, the second company to supply about two-thirds of the drug to the US market.

CNBC Health & Science

Read the latest global health coverage on CNBC:

The 5th Circuit Court’s decision by Justices Kurt Engelhardt and Andrew Oldham, also appointed by Trump, essentially reverses all steps the FDA has taken to make mifepristone more accessible to women. rice field.

The Justice Department told the Supreme Court that following the Fifth Circuit’s ruling would have violated Rice’s order by the government.

The Alliance Defending Freedom, an anti-abortion group that has filed a lawsuit against the FDA’s approval of mifepristone, has asked the Supreme Court to maintain restrictions on the drug. Restrictions, they argued, provide important protections that keep patients safe. The legal organization represents a group of doctors who oppose abortion called the Hippocratic Medical Alliance.

League of Liberty Said to have helped draft Mississippi law Finally, last summer, the Supreme Court overturned Roe v. Wade. Roe v. Wade was a landmark 1973 decision that made abortion a constitutional right guaranteed nationwide.of Group says it’s exclusive “To protect freedom of religion, freedom of speech, sanctity of life, parental rights, and God’s plan for marriage and family.”

The Department of Justice and Danko said the lower court’s ruling would essentially keep mifepristone off the market for months as the FDA adjusts drug labeling to comply with the Court of Appeals order. would prevent many women from having access to safe and effective FDA-approved alternatives to surgical abortion, they argued.

Anti-abortion groups claim that the way the FDA approved mifepristone is illegal and that the drug is unsafe. These claims are hotly contested by former FDA officials, major medical associations, the pharmaceutical industry, 23 US states, and hundreds of members of Congress.

They say the FDA has conducted rigorous reviews that have determined that mifepristone is safe and effective, which is confirmed by decades of subsequent data.

A group of pharmaceutical companies, including Pfizer, biotech executives and investors, told the Supreme Court that letting the lower court’s ruling stand “is the FDA’s gold standard for reviewing scientific safety and efficacy.” I will smash it,” he said. A former FDA official told the High Court that the ruling was effective. create an open season This allows competing pharmaceutical companies and those who claim that the drug had side effects to sue to remove the drug from the market.

Summarize this content to 100 words Demonstrators support abortion rights at the US Supreme Court in Washington, DC, April 15, 2023. Andrew Caballero-Reynolds | AFP | Getty ImagesSupreme Court Justice Samuel Alito issued an order Wednesday making the abortion drug mifepristone available by mail without severe restrictions on its use until at least late Friday night.Alito temporarily blocked restrictions last week Mifepristone It was imposed by a lower federal court until 11:59 p.m. Wednesday in response to an emergency motion by the Department of Justice and Danco Laboratories, distributors of the brand-name drug Mifeprex.These restrictions will remain in place until 11:59 PM on Friday as a result of his new order.Alito did not explain the reason for the delay.But as a complicated legal battle unfolds over mifepristone, he and the rest of the Supreme Court are weighing whether to keep the lower court’s judgment pending or allow mifepristone restrictions to take effect. You will be given an additional two days to do so.Two separate federal courts have handed down conflicting rulings against the Food and Drug Administration regarding drug availability.Earlier this month, U.S. Judge Matthew Kaksmalik for the Northern District of Texas pause FDA approval of mifepristone and all subsequent decisions made by the FDA to regulate the drug.US Court of Appeals for the Fifth Circuit partially blocked Kacsmaryk’s sweeping order went into effect a few days later, keeping FDA approval in effect but imposing severe restrictions on how mifepristone could be used and distributed. That ruling keeps mifepristone on the market, but the restrictions are so widespread that even in some states where abortion is legal, many women don’t have access to the drug.Shortly after Kacsmaryk’s ruling, Judge Thomas Rice of the Eastern District of Washington said: FDA restricts access to mifepristone in 17 states and Washington DCMifepristone, used in combination with another drug called misoprostol, is the most common method of aborting pregnancies in the United States, accounting for about half of all abortions. According to the Centers for Disease Control Prevention and the Guttmacher Institute.Kacsmaryk’s unprecedented ruling marks the first time a federal court has overturned the FDA’s determination that a drug is safe and effective, according to court filings from the Department of Justice, former FDA employees, and the pharmaceutical industry. was.Former President Donald Trump appointed Kaksmalik. Senate Democrats voted unanimously against his nomination, citing concerns about his position on abortion and LGBTQ rights.Appeals court restrictions include blocking the mailing of drugs, reimposing a doctor’s visit as a requirement to obtain drugs, and shortening the period during which women can use the pill to seven weeks pregnant. The court also blocked a generic version of mifepristone manufactured by GenBioPro, the second company to supply about two-thirds of the drug to the US market.CNBC Health & Science Read the latest global health coverage on CNBC:The 5th Circuit Court’s decision by Justices Kurt Engelhardt and Andrew Oldham, also appointed by Trump, essentially reverses all steps the FDA has taken to make mifepristone more accessible to women. rice field.The Justice Department told the Supreme Court that following the Fifth Circuit’s ruling would have violated Rice’s order by the government.The Alliance Defending Freedom, an anti-abortion group that has filed a lawsuit against the FDA’s approval of mifepristone, has asked the Supreme Court to maintain restrictions on the drug. Restrictions, they argued, provide important protections that keep patients safe. The legal organization represents a group of doctors who oppose abortion called the Hippocratic Medical Alliance.League of Liberty Said to have helped draft Mississippi law Finally, last summer, the Supreme Court overturned Roe v. Wade. Roe v. Wade was a landmark 1973 decision that made abortion a constitutional right guaranteed nationwide.of Group says it’s exclusive “To protect freedom of religion, freedom of speech, sanctity of life, parental rights, and God’s plan for marriage and family.”The Department of Justice and Danko said the lower court’s ruling would essentially keep mifepristone off the market for months as the FDA adjusts drug labeling to comply with the Court of Appeals order. would prevent many women from having access to safe and effective FDA-approved alternatives to surgical abortion, they argued.Anti-abortion groups claim that the way the FDA approved mifepristone is illegal and that the drug is unsafe. These claims are hotly contested by former FDA officials, major medical associations, the pharmaceutical industry, 23 US states, and hundreds of members of Congress.They say the FDA has conducted rigorous reviews that have determined that mifepristone is safe and effective, which is confirmed by decades of subsequent data.A group of pharmaceutical companies, including Pfizer, biotech executives and investors, told the Supreme Court that letting the lower court’s ruling stand “is the FDA’s gold standard for reviewing scientific safety and efficacy.” I will smash it,” he said. A former FDA official told the High Court that the ruling was effective. create an open season This allows competing pharmaceutical companies and those who claim that the drug had side effects to sue to remove the drug from the market.
https://www.cnbc.com/2023/04/19/supreme-court-rules-on-abortion-pill-mifepristone.html Supreme Court decision on abortion drug mifepristone

Exit mobile version